C
CNSP
CNS Pharmaceuticals
6.05
+0.11+1.85%Opening10:41 08/25 EDT
OPEN/PREV CLOSE5.74/5.94
TODAY RANGE5.74-6.05
VOL6.84K
MARKET CAP8.84M
52 WEEK RANGE1.900-10.59
AVG VOL (3M)28.61K
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-0.2614
% RANGE5.23%
EPS(TTM)-23.1416
P/E(FORWARD)-3.6667
P/B0.4858
BVPS12.45
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.76M
SHARES OUTSTANDING1.46M
NEXT EARNINGS11/12-11/16
FREE FLOAT1.45M
LOT SIZE1
EX-DATE07/22/2025
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
Insider Move at CNS Pharmaceuticals Sparks Investor Buzz
TipRanks·08/17 09:41
CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year
Seeking Alpha·08/12 12:05
CNS Pharmaceuticals GAAP EPS of -$0.37 misses by $0.13
Benzinga·07/14 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·07/02 11:58
CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment
Benzinga·07/01 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·05/26 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·05/21 02:09
Insider Boost: CNS Pharmaceuticals Director Quietly Ramps Up His Stake
TipRanks·05/19 21:01
CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders
TipRanks·05/15 13:26
Maxim Group Sticks to Their Buy Rating for CNS Pharmaceuticals (CNSP)
TipRanks·05/14 16:25
CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year
TipRanks·05/14 16:22
CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months
Benzinga·05/14 12:28
CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate
Seeking Alpha·05/14 12:06
CNS Pharmaceuticals reports Q1 results
Same Industry
Name/Symbol
Change%
Price